Blood test measuring Rubella IgM antibodies, which typically appear during a recent or active rubella infection rather than long-term immunity. Suited to people with recent rubella-type symptoms or a known exposure.
1 biomarker as listed by Better2Know.
This test checks for Rubella IgM antibodies. Better2Know's own information explains that IgM antibodies are typically the first your immune system produces after rubella infection, appearing as the rash starts to fade, so a positive result together with a positive IgG suggests a recent or active infection rather than long-standing immunity. Better2Know advises that if both come back positive, testing should be repeated in three to four weeks, or sooner if symptoms develop.
Counted as a single biomarker, this test sits around the middle of the range for clinical depth among the immunity tests we track. Its £195 price is above the median for similarly sized immunity tests, which is the main reason it scores below average on value for money. The listing is clear, with a full description, the biomarker tested, a stated one-day turnaround and clear collection options.
The remaining scores reflect collection and follow-up. You can have blood drawn at a clinic or by a home nurse visit, with results ready the next working day. Results are not doctor-reviewed as standard, which is the main reason it loses marks on results and follow-up; Better2Know says a positive result should prompt medical attention, particularly during pregnancy, and that it can arrange a private consultation. Trust signals reflect a 4.2 Trustpilot score from 775 reviews, CQC registration, and 18 years trading.
This suits you if you have recent rubella-type symptoms, such as a rash, fever or swollen lymph nodes, or a known recent exposure, and want to check for markers of an active infection rather than long-term immunity.
If you mainly need to confirm long-term immunity rather than investigate current symptoms, an IgG-only immunity check would be more relevant; Better2Know has not linked this test to a named group of comparable products, so there is no pricing data here to compare. If you are pregnant and have symptoms, see a GP promptly rather than relying on this test alone.
You provide a venous blood sample at a Better2Know clinic, or a nurse can visit you to take the sample. The sample is analysed for Rubella IgM antibodies, with results ready within one working day of the sample reaching the lab. You view your results through Better2Know's online patient area, and the patient services team contacts you once they are ready. Results are not doctor-reviewed as standard.
This test measures Rubella IgM antibodies, which typically appear during a recent or active infection rather than long-term immunity. At £195, it costs more than the typical price for similarly sized immunity tests we track. Results are not doctor-reviewed as standard.
The listing publishes a detailed description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
1 biomarkers, placing it in the 36th percentile of immunity tests we track.
Requires a venous draw at a clinic; a home nurse visit is offered; results in around 1 days, well ahead of the immunity norm of 3.
Results are not doctor-reviewed and no consultation is included; the provider does not describe the report format.
Trustpilot 4.2 from 775 reviews; CQC registered; trading 18+ years.
£195.00 against a median of £129.00 for the 79 similarly sized immunity tests we track (+51%).
Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.
Highly rated for depth and priced well below the market
An 8-marker blood test covering white and red blood cells, vitamin D, B12, iron status and inflammation, for a broad check of immune-related health.
Six-marker immunity panel below the category median
A six-marker blood panel covering IgG, IgM and IgA antibodies plus total protein, albumin and globulin, for anyone investigating frequent infections or possible immune deficiency.
Combined Covid tests, discontinued from 30 Sept 2026
A combined blood test measuring both nucleocapsid antibodies, which indicate past infection, and spike protein antibodies, which indicate a vaccine or infection response.
Broad 13-marker urine panel, competitively priced
A urine analysis under the microscope plus a culture to check for bacteria, covering signs of infection, kidney health and metabolic changes. Suits monitoring urinary symptoms or investigating an abnormal result.
